Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

New sulfonamide anticoagulants in the Takeda pipeline

Sep. 28, 1999

Tanabe Seiyaku presents PAI-1 inhibitors as antithrombotics

Sep. 27, 1999

Meiji Seika's new integrin receptor antagonists useful as antiplatelet, antiadhesion agents

Sep. 22, 1999

Health Canada approves Aggrastat for management of unstable angina

Sep. 20, 1999

Mediolanum and Dompe introduce new agent for preventing DVT in Italy

Sep. 20, 1999

Human factor Xa inhibitors under evaluation at Roche Diagnostics

Sep. 16, 1999

Corvas and Schering-Plough extend oral anticoagulant research program

Sep. 15, 1999

International patent covers Roche Diagnostics' new anticoagulants

Sep. 15, 1999

Prophylaxis of venous thromboembolism with enoxaparin assessed in hospitalized patients

Sep. 14, 1999

Preparation and use of P2T receptor antagonists in AstraZeneca's portfolio

Sep. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...